:: Event ::
| Evaluating Technical and Market Risk |
|
Where: IUETC (Directions) |
| When: 10/13/2009 at 5pm |
Every company must continually evaluate technical and market risk in order to properly allocate resources and reach milestones. What challenges do technologies face in the marketplace and in development and how do you address them? Join IBEN in discussing this topic and learning what strategies are used to evaluate, approach, and minimize risk. |
Cost is free, but registration is required. |
|
**This event has already occurred.** |
|
Speaker(s):
Wade Lange, President & CEO, Immuneworks
Andrew Cothrel, President, SonarMed |
|
Moderator(s):
Jack Pincus
|
|
Biographies: Wade Lange: Wade Lange has more than 27 years of experience in the pharmaceutical and contract clinical research industry. Wade was responsible for market research and pre-launch product planning for Lilly’s Prozac antidepressant. After his time at Lilly, he built Walker Clinical Evaluations’ successful contract clinical research organization; during this time he managed the sale of the business to a strategic buyer. Wade then led the Indiana Health Industry Forum, Indiana’s life sciences association, to a leadership position in Indiana’s economic development program. Wade received a BS in Pharmacy from Purdue University and an MS in Industrial Administration from the Krannert Graduate School of Management at Purdue. Andrew Cothrel: Mr. Cothrel is veteran medical device executive with 20 years of industry experience in general management, development/commercialization, operations and strategy including a VP role at Roche and CEO roles at multiple early-stage companies. |